Penumbra Announces Pricing Of Offering Of 1,300,000 Shares Of Its Common Stock Post author:Sam Post published:March 16, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Dermira’s Acne Medication Olumacostat Glaseretil Tanks in Two Phase III Trials March 4, 2018 BlueRock Therapeutics Expands Toronto Presence With R&D And Manufacturing Hub, Appoints Key R&D Leadership August 16, 2017 Lysogene Reinforces Its Management Team With The Nomination Of As Chief Operating Officer May 16, 2017
BlueRock Therapeutics Expands Toronto Presence With R&D And Manufacturing Hub, Appoints Key R&D Leadership August 16, 2017
Lysogene Reinforces Its Management Team With The Nomination Of As Chief Operating Officer May 16, 2017